First Trust Capital Management’s Exact Sciences EXAS Stock Holding History

First Trust Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-274,864	Closed	-$27.9M	–	191
2025 Q4	$27.9M	Buy	+274,864	New	+$22.1M	1.69%	13

Other funds holding EXAS

VanEck Associates

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

First Trust Capital Management's EXAS Position: Q1 2026 in Review

First Trust Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 274,864 shares — an estimated $27.9M sold.

First Trust Capital Management first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $27.9M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

First Trust Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
First Trust Capital Management sold 274,864 Exact Sciences shares in Q1 2026, an estimated $27.9M.
First Trust Capital Management first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
First Trust Capital Management's Exact Sciences position peaked at $27.9M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on First Trust Capital Management's 13F filing for Q1 2026, filed 14 May 2026.